GVHD (acute or chronic)
Showing 1 - 25 of >10,000
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
Dendritic Cells in Acute or Chronic Skin Graft Versus Host
Recruiting
- Acute Graft-versus-host Disease
- +3 more
- Skin punch biopsy
- Peripheral blood draw
-
Saint Louis, MissouriWashington University School of Medicine
May 31, 2022
GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)
Recruiting
- GVHD,Acute
- GVHD, Chronic
- Physical exercise
-
Salamanca, SpainUniversity of Salamanca
May 27, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))
Recruiting
- Graft Versus Host Disease
- Cyclophosphamide
- anti-human T-lymphocyte immunoglobulin (ATLG)
-
Ramat Gan, IsraelChaim Sheba Medical Center
May 4, 2022
Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention
Recruiting
- Graft Vs Host Disease
- +2 more
- Exercise
- Attention control
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Dec 21, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)
Not yet recruiting
- Allogeneic Disease
- +2 more
- WJ-MSC infusion
- (no location specified)
May 4, 2023
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021
Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)
Recruiting
- Chronic Graft-Versus-Host Disease
- +2 more
- Rapamycin
- T regulatory cells
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Apr 27, 2021
GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))
Completed
- Graft Versus Host Disease
- +2 more
- Autologous mesenchymal stromal cells (MSCs)
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Mar 2, 2021
Acute GVHD Trial (MTX, Corticosteroid)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Jun 26, 2023
GVHD,Acute Trial (OSSM-001)
Withdrawn
- GVHD,Acute
- OSSM-001
- (no location specified)
Dec 21, 2022
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,
Withdrawn
- Acute Myeloid Leukemia
- +2 more
- Atorvastatin
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 23, 2021
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia (ALL) in Partial Remission
- +2 more
- Cyclophosphamide 50mg
- Methotrexate
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Center
Apr 4, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +5 more
-
New York, New YorkColumbia University Medical Center
Aug 4, 2021
GVHD, Chronic, Acute Leukemia, Stem Cell Transplant Complications Trial in Bologna
Completed
- GVHD, Chronic
- +2 more
-
Bologna, Bo, ItalyHematology - Sant'Orsola-Malpighi Hospital
Mar 18, 2021